Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07559903 · ClinicalTrials.gov registry record
ANDREAS Registry (Assessment of Novel Drug-coated Balloon Revascularization: Effectiveness, Angiographic Outcomes, and Safety)
A clinical trial, sponsored by Emory University.
- Recruiting
- Registry status
- 5,000
- Enrollment target
NCT07559903 is a clinical trial that is actively recruiting participants, run by Emory University. The registered enrollment target is 5,000 participants.
The verdict
NCT07559903 is actively recruiting participants, sponsored by Emory University.
- RECRUITING
- Registry status
- 5,000 participants
- Enrollment target
Study Summary
The primary objective of this protocol is to develop a comprehensive, multicenter international prospective registry to capture long-term clinical outcomes for adult patients undergoing percutaneous coronary intervention (PCI) with drug-coated balloons (DCB) for de novo coronary artery disease.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5,000 participants |
| Start Date | 2026-06 |
| Est. Completion | 2031-05 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07559903
The ClinicalTrials.gov registry entry for NCT07559903 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 5,000 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Emory University, which has 1,208 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT07559903 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07559903 about?
NCT07559903 is a clinical study titled "ANDREAS Registry (Assessment of Novel Drug-coated Balloon Revascularization: Effectiveness, Angiographic Outcomes, and Safety)". The primary objective of this protocol is to develop a comprehensive, multicenter international prospective registry to capture long-term clinical outcomes for adult patients undergoing percutaneous coronary intervention (PCI) with drug-coated balloons (DCB) for de novo coronary artery disease.
What is the current status of trial NCT07559903?
This trial is currently recruiting. The enrollment target is 5,000 participants. The study started on 2026-06. Estimated completion is 2031-05.
Who is sponsoring clinical trial NCT07559903?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.